Zenith Flex G55204Recalls & reported problems
Cook Incorporated · Zenith Flex, AAA Endovascular Graft Main Body Extension · Class 3 · Implant
All models of Zenith Flex (54)
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 1
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 10827002552040), received between Sep 14, 2020 and Sep 14, 2020 — classified as 1 malfunction.
The most frequently reported specific device problem is “Failure to Advance” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Most reported problems
Device problems
- Failure to Advance1
Patient problems
- No Consequences Or Impact To Patient1
Recent adverse event reports
The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.
MalfunctionSep 14, 2020Failure to Advance; Failure to Advance
IT WAS REPORTED THAT THERE WAS DIFFICULTY EXPERIENCED ADVANCING A WIRE GUIDE THROUGH A ZENITH FLEX WITH Z-TRAK AAA ENDOVASCULAR GRAFT MAIN BODY EXTENSION DELIVERY SYSTEM DURING AN ENDOVASCULAR REPAIR OF A FONTAN BAFFLE. THE LUMEN OF THE DEVICE SEEMED TO BE "BLOCKED" AS MULTIPLE COOK AND COMPETITOR WIRE GUIDES WERE UNABLE TO PASS THROUGH THE DEVICE. THE DEVICE WAS TO BE PLACED IN THE PATIENT'S VENOUS SYSTEM. A "MUSTARD PROCEDURE" HAD BEEN PREVIOUSLY COMPLETED. DURING THE REPAIR, THE DEVICE WAS UNABLE TO BE LOADED ONTO THE WIRE AND THEREFOR COULD NOT BE INTRODUCED INTO THE PATIENT. ULTIMATELY, THE INTENDED GRAFT WAS UNABLE TO BE IMPLANTED; IN ITS PLACE, A COMPETITOR BALLOON EXPANDABLE STENT GRAFT WAS SUCCESSFULLY IMPLANTED. IT WAS ALSO REPORTED THAT THE PHYSICIAN WAS AWARE PRIOR TO THE PROCEDURE THAT THE DEVICE WAS BEING USED OFF-LABEL. THE GRAFT WAS NOT ALTERED PRIOR TO IMPLANT. NO ADDITIONAL PROCEDURES WERE NECESSARY AND THE PATIENT DID NOT EXPERIENCE ANY ADVERSE EFFECTS AS A RESULT OF THIS EVENT.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 10530853 ↗
Other SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT devices
- Endurant® IIs ESBF2814C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls34 deaths254 reports
- Endurant® IIs ESBF3214C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls19 deaths173 reports
- Endurant® IIs ESBF3614C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT1 recall37 deaths214 reports
- Endurant® IIs ESBF2514C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls18 deaths136 reports
- Endurant® IIs ESBF2314C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls9 deaths60 reports
- RelayPro Thoracic Stent-Graft System 28-N4-34-154-34UBolton Medical Inc. · System, Endovascular Graft, Aortic Aneurysm Treatment3 recalls7 reports
- Vela Proximal Endograft System A34-34/C100-O20 VEndologix LLC · System, Endovascular Graft, Aortic Aneurysm Treatment3 deaths152 reports
- Endurant® II ETCF2828C49EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls7 deaths44 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page